SCHEMBL7092653

SCHEMBL7092653

CC1Oc2ccc(C(NC(=O)OC(C)(C)C)C(c3ccccc3)c3ccccc3)cc2NC1=S

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.39
ALDH1A1 P00352 2/20 0.39
RCE1 Q9Y256 1/20 0.39
IDO1 P14902 1/20 0.37
CTSK P43235 3/20 0.36
CTSS P25774 1/20 0.36
MAPT P10636 2/20 0.36
PLA2G1B P04054 1/20 0.36
HPGD P15428 1/20 0.36
XBP1 P17861 1/20 0.36
HTT P42858 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36
ATG4B Q9Y4P1 1/20 0.36
GABRB1 P18505 1/20 0.35
GABRB2 P47870 1/20 0.35
PARP1 P09874 1/20 0.34
CCKAR P32238 1/20 0.33
CCKBR P32239 1/20 0.33
MAPK1 P28482 1/20 0.33
S1PR3 Q99500 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7711126 0.89 PARP1 (0.45) KDM4EALDH1A1RCE1IDO1CTSK
SCHEMBL7704943 0.84 ALDH1A1 (0.43) ALDH1A1CTSKCTSSMAPTHPGD
SCHEMBL7089999 0.82 KDM4E (0.37) KDM4EALDH1A1RCE1IDO1CTSK
SCHEMBL7087735 0.79 MC4R (0.36) KDM4EALDH1A1RCE1IDO1CTSK
SCHEMBL7095873 0.79 CTSS (0.42) KDM4EALDH1A1RCE1IDO1CTSK
SCHEMBL7093745 0.78 KDM4E (0.34) KDM4EALDH1A1RCE1IDO1CTSK
SCHEMBL6304809 0.78 MAPT (0.39) KDM4EALDH1A1RCE1MAPTPLA2G1B
SCHEMBL7095640 0.78 ALDH1A1 (0.37) KDM4EALDH1A1RCE1MAPTPLA2G1B
SCHEMBL5472786 0.77 MAPT (0.41) KDM4EALDH1A1RCE1IDO1CTSK
SCHEMBL7092472 0.77 HSD17B10 (0.37) ALDH1A1MAPTHPGDXBP1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1015437-B1 BENZOXAZINE AND BENZOTHIAZINE DERIVATIVES AND THEIR USE IN PHARMACEUTICALS SCHERING AG (DE) 2003-12-03 EP disclosed
US-6365736-B1 TREATMENT OF NERVOUS SYSTEM DISORDERS, CARDIOVASCULAR DISORDERS AND FOR ACTIVITY AS NO-SYNTHASES (NOS) INHIBITORS. SCHERING AKTIENGESELLSCHAFT (DE) 2002-04-02 US disclosed